e-learning
resources
Berlin 2008
Wednesday, 08.10.2008
Biology and diagnosis of thoracic tumours
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Two-pore domain K+ channel TASK-1 maintains the membrane potential in non-small cell lung cancer (NSCLC) cells
K. Leithner, C. Wohlkoenig, Y. Li, B. Tang, C. Nagaraj, A. Olschewski, H. Olschewski (Graz, Austria)
Source:
Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Session:
Biology and diagnosis of thoracic tumours
Session type:
E-Communication Session
Number:
4699
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Leithner, C. Wohlkoenig, Y. Li, B. Tang, C. Nagaraj, A. Olschewski, H. Olschewski (Graz, Austria). Two-pore domain K+ channel TASK-1 maintains the membrane potential in non-small cell lung cancer (NSCLC) cells. Eur Respir J 2008; 32: Suppl. 52, 4699
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Mitochondrial depolarization and annexin V binding in CD3+T cells in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 357s
Year: 2004
TASK-1 (KCNK3) channels in the lung: from cell biology to clinical implications
Source: Eur Respir J, 50 (5) 1700754; 10.1183/13993003.00754-2017
Year: 2017
The role of amiloride sensitive epithelial sodium channel (ENaC) in cell migration of mesothelioma cells is dependent on the cell type and the extracellular matrix
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Roles of volume-sensitive Cl
-
channel in cisplatin resistance of human lung adenocarcinoma cells
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010
HIF-1α modulation by topoisomerase inhibitors in A549, a non-small cell lung cancer cell line
Source: Annual Congress 2007 - Biology in thoracic oncology
Year: 2007
Analysis of the prognosis value of the mitochondrial activity in resected non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
Over-expression of aquaporin-5 increases migration and metastatic potential of lung cancer cells
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009
Identification of a TRPM7-like non-selective cation channel in human lung mast cells
Source: Eur Respir J 2004; 24: Suppl. 48, 453s
Year: 2004
IRP2 as a potential modulator of cell proliferation, apoptosis and prognosis in nonsmall cell lung cancer
Source: Eur Respir J , 49 (4) 1600711; DOI: 10.1183/13993003.00711-2016
Year: 2017
The role of aquaporin-1 (AQP1) and amiloride sensitive epithelial sodium (ENaC) in cell adhesion of mesothelioma cells is cell and extracellular matrix type dependent
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Methylation for cystic fibrosis transmembrane regulator gene in nonsmall cell lung cancer
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009
TRPA1 ion channel expression in human lung myofibroblasts
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019
Global screening of AKT/PI3K signaling molecules for non-small cell lung cancer and its prognosis
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
Expression and function of the 67 kDa high-affinity laminin receptor in nonsmall cell lung carcinoma
Source: Eur Respir J 2002; 20: Suppl. 38, 13s
Year: 2002
Characterization of patients with non-small cell lung cancer (NSCLC) relative to its EGFR mutational status
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011
Cyclooxygenase(COX)-2 is over-expressed in non small cell lung cancer (NSCLC) and is a potential target for treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 400s
Year: 2002
MiR-34a favours macrophage polarization switch from M2 to M1 phenotype in non small cell lung cancer (NSCLC)
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
Adaptation to hypoxia leads to apoptosis resistance to cisplatin in non-small cell lung cancer (NSCLC) cell line
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
Prognostic and potential therapeutic impact of prostate specific membrane antigen expression in non-small cell lung cancer
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
Ion channel modulation by adenosine in human lung mast cells
Source: Eur Respir J 2005; 26: Suppl. 49, 225s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept